Letrozole co-treatment in an antagonist protocol for overweight women undergoing IVF treatment: a retrospective study
Abstract Background Overweight women undergoing IVF treatment have lower success rates. Letrozole, an aromatase inhibitor, has been used as an adjunct for IVF treatment, but its specific effects in overweight women have not been investigated. This study was to explore the effects of letrozole co-tre...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-09-01
|
| Col·lecció: | BMC Pregnancy and Childbirth |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12884-024-06795-3 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
